Condition

Chemotherapeutic Agent Toxicity

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 11 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials11

Recruiting1

Common interventions25

Lead sponsors shown10

Clinical trials

11 shown

Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.NCT06387901 · 2024-07-30

RECRUITING

Diminish Chemotherapy Related Side Effects Through Patient EducationNCT04694794 · 2021-03-24

COMPLETED

Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing ChemotherapyNCT04632797 · 2020-02-03

UNKNOWN

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)NCT01562301 · 2014-06-01

WITHDRAWN

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelNCT01243541 · 2010-11-03

TERMINATED

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoNCT00775645 · 2009-09-01

COMPLETED

First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung CancerNCT01097317 · 2009-09-01

UNKNOWN

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast CancerNCT00771433 · 2007-10-01

COMPLETED

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast CancerNCT00751101 · 2007-08-20

TERMINATED

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast CancerNCT00755313 · 2007-05-01

COMPLETED

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast CancerNCT00754767 · 2007-01-02

TERMINATED

Common interventions

Leading sponsors

University of California, San Francisco 2 Centre Francois Baclesse 1 HealthPartners Institute 1 M.D. Anderson Cancer Center 1 Medical University Innsbruck 1 Milton S. Hershey Medical Center 1 Northwestern University 1 SWOG Cancer Research Network 1 Universitair Ziekenhuis Brussel 1 Wales Cancer Trials Unit 1

Trial status mix

COMPLETED4

TERMINATED3

UNKNOWN2

RECRUITING1

WITHDRAWN1

Phase mix

NA3

PHASE23

PHASE11

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.